AR055862A1 - Uso de un compuesto de anetol ditioltiona para preparar una composicion farmaceutica; dicha composicion y el compuesto - Google Patents

Uso de un compuesto de anetol ditioltiona para preparar una composicion farmaceutica; dicha composicion y el compuesto

Info

Publication number
AR055862A1
AR055862A1 ARP060100616A ARP060100616A AR055862A1 AR 055862 A1 AR055862 A1 AR 055862A1 AR P060100616 A ARP060100616 A AR P060100616A AR P060100616 A ARP060100616 A AR P060100616A AR 055862 A1 AR055862 A1 AR 055862A1
Authority
AR
Argentina
Prior art keywords
disorders
disorder
compound
substance
compounds
Prior art date
Application number
ARP060100616A
Other languages
English (en)
Spanish (es)
Inventor
Benjamin Drukarch
Anton N M Schoffelmeer
Roelof W Feenstra
Marie-Odile Christen
Jean-Louis Burgot
Marylene Chollet
Bakker Wouter I Iwema
Vliet Bernard J Van
Martinus Th M Tulp
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of AR055862A1 publication Critical patent/AR055862A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP060100616A 2005-02-24 2006-02-21 Uso de un compuesto de anetol ditioltiona para preparar una composicion farmaceutica; dicha composicion y el compuesto AR055862A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05101405 2005-02-24

Publications (1)

Publication Number Publication Date
AR055862A1 true AR055862A1 (es) 2007-09-12

Family

ID=34938805

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060100616A AR055862A1 (es) 2005-02-24 2006-02-21 Uso de un compuesto de anetol ditioltiona para preparar una composicion farmaceutica; dicha composicion y el compuesto

Country Status (14)

Country Link
EP (1) EP1858875A2 (zh)
JP (1) JP2008531519A (zh)
KR (1) KR20070117607A (zh)
CN (1) CN101107240B (zh)
AR (1) AR055862A1 (zh)
AU (1) AU2006218012A1 (zh)
BR (1) BRPI0609043A2 (zh)
CA (1) CA2594165A1 (zh)
MX (1) MX2007010380A (zh)
RU (1) RU2402543C2 (zh)
SA (1) SA06270023B1 (zh)
TW (1) TW200640898A (zh)
UA (1) UA94579C2 (zh)
WO (1) WO2006089861A2 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0704718D0 (en) * 2007-03-12 2007-04-18 Prendergast Patrick T Compounds and methods for preventing and treating mucositis
CN102807557B (zh) * 2012-08-21 2015-02-04 苏州大学 3h-1,2-二硫环戊烯-3-硫酮类化合物及其应用
KR101438415B1 (ko) * 2013-07-25 2014-09-17 동국대학교 경주캠퍼스 산학협력단 기억력 손상의 예방 또는 개선을 위한 조구등 추출물
CN104788440B (zh) * 2015-04-03 2017-12-26 苏州大学 烟酸衍生物及其应用
FR3063640B1 (fr) * 2017-03-07 2020-10-09 Elodie Petitjean Traitement de la fibrose pulmonaire a l'aide d'un inhibiteur selectif de la production d'especes reactives de l'oxygene d'origine mitochondriale
EP3592348A1 (en) 2017-03-07 2020-01-15 Op2 Drugs Desmethylanethole trithione derivatives for the treatment of diseases linked to mitochondrial reactive oxygen species (ros) production
AU2019341666A1 (en) * 2018-09-18 2021-05-13 St Ip Holding Ag Rotomeric isomers of 4-alkyl-5-heteroaryl-3H-1,2- dithiole-3-thiones

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1442450A (fr) * 1964-05-05 1966-06-17 Monsanto Chemicals Nouveaux composés hétérocycliques contenant du soufre
JPH089611B2 (ja) * 1988-06-20 1996-01-31 三井東圧化学株式会社 新規１，２−ジチオール−３−チオン誘導体およびそれを有効成分とする免疫調節剤
WO1998027970A2 (en) * 1996-12-24 1998-07-02 National Research Council Of Canada Treatment of diseases or prevention of cellular damage caused by oxygen-containing free radicals
WO2001009118A2 (en) * 1999-07-29 2001-02-08 Patrick T Prendergast Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement

Also Published As

Publication number Publication date
MX2007010380A (es) 2007-09-25
UA94579C2 (ru) 2011-05-25
CA2594165A1 (en) 2006-08-31
WO2006089861A3 (en) 2006-10-26
KR20070117607A (ko) 2007-12-12
RU2007135184A (ru) 2009-03-27
CN101107240A (zh) 2008-01-16
CN101107240B (zh) 2011-02-09
RU2402543C2 (ru) 2010-10-27
SA06270023A (ar) 2005-12-03
TW200640898A (en) 2006-12-01
JP2008531519A (ja) 2008-08-14
AU2006218012A1 (en) 2006-08-31
EP1858875A2 (en) 2007-11-28
BRPI0609043A2 (pt) 2010-11-16
SA06270023B1 (ar) 2010-10-12
WO2006089861A2 (en) 2006-08-31

Similar Documents

Publication Publication Date Title
AR055862A1 (es) Uso de un compuesto de anetol ditioltiona para preparar una composicion farmaceutica; dicha composicion y el compuesto
AR059895A1 (es) Derivados biciclicos de acidos carboxilicos que resultan de utilidad para tratar trastornos metabolicos
US11453666B2 (en) Autotaxin inhibitory compounds
KR101450172B1 (ko) 페놀 유도체 및 이의 약학적 또는 화장품 용도
US7410963B2 (en) Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof
CA3001666A1 (en) Oxadiazole amine derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
PE20061123A1 (es) Derivados de amida como inhibidores de la hidrolasa de amida de acido graso
ECSP099496A (es) Compuestos inhibidores de fosfofinosítido 3-quinasas y métodos de uso
JP2010540508A (ja) イミダゾロチアジアゾール類のプロテインキナーゼ阻害剤としての使用
AR051738A1 (es) Derivados de piridazin-3(2h)-ona, composicin farmaceutica, y uso del compuesto para fabricar medicamentos
ECSP066829A (es) 5,6 dialquil-7 -amino-triazolopirimidinas, procedimientos para su preparacion y el uso de las mismas para combatir hongos nocivos
PE20090813A1 (es) Inhibidores de la 11b-hidroxiesteroide-deshidrogenasa
AR063454A1 (es) Derivados acetamida de diazepan como inhibidores selectivos de 11 beta - hsd1. procesos de obtencion y composiciones farmaceuticas.
NZ595778A (en) Fused pyrimidineone compounds as trpv3 modulators
AR085960A1 (es) 1,3-oxazinas como inhibidores de la bace1 y/o de la bace2
Satish et al. Copper-catalyzed oxidative amination of methanol to access quinazolines
WO2020253814A1 (zh) 一类雷公藤红素衍生物、其制备方法及用途
AR070898A1 (es) Derivados de arilsulfonil pirazolin carboxamidina como antagonistas de 5-ht6
CA2866113A1 (en) Pyrazolyl derivatives as liver x receptor (lxr) modulators for the treatment of dermal diseases, disorders and conditions
PE20140998A1 (es) Compuestos heterociclicos como inhibidores de syk
CA2895606A1 (fr) Saturated nitrogen and n-acylated heterocycles potentiating the activity of an active antibiotic against mycobacteria
CA2784600A1 (en) New inhibitors of cyclophilins and uses thereof
KR20210033003A (ko) 티아디아진 유도체
Perupogu et al. Anticancer activity of newly synthesized 1, 2, 4-oxadiazole linked 4-(oxazolo [5, 4-d] pyrimidine derivatives
KR20150104865A (ko) 플라본 유도체 및 그를 포함하는 항암제 조성물

Legal Events

Date Code Title Description
FA Abandonment or withdrawal